Yazar "Mertsoylu, H." için listeleme
-
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse
Kose, Fatih; Alemdaroglu, S.; Mertsoylu, H.; Besen, A.; Guler, O.; Simsek, S.; Erbay, G.; Onal, C.; Celik, H. (2019) -
Clinicohistopathological Features and Treatment Outcomes of Neuroendocrine Tumors; A Single Center Experience
Sumbul, A. T.; Sedef, A. M.; Kose, F.; Mertsoylu, H.; Sezer, A.; Ozyilkan, O.; Abali, H. (2017) -
CONCURRENT CHEMORADIOTHERAPY WITH VINORELBINE PLUS SPLIT-DOSE CISPLATIN IN INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER
Mertsoylu, H.; Kose, F.; Sedef, A.M.; Dogan, O.; Parlak, C.; Besen, A.A.; Sumbul, A.T.; Findikcioglu, A.; Sezer, A.; Muallaoglu, S. (2015) -
Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in Inoperable Stage III NSCLC
Calikusu, Z.; Ugurluer, G.; Serin, M.; Sedef, A. M.; Mertsoylu, H.; Besen, A.; Kose, F. (2017) -
Initial presentation of prostate cancer may hint different clinical characteristics along with serving predictive biomarker in castration-resistant prostate cancer patients treated with abiraterone acetate
Kose, F.; Sedef, A.; Besen, A.; Mertsoylu, H. (2019) -
Predictive and prognostic role of T-regulatory cells in resected non-small cell lung cancer
Kose, F.; Findikcioglu, A.; Canpolat, T.; Sedef, A.M.; Besen, A.; Mertsoylu, H.; Ozyilkan, O.; Abali, H. (2016) -
PROGNOSTIC ROLE OF T-REGULATORY CELLS IN COMPLETELY RESECTED EARLY STAGE NON-SMALL CELL LUNG CARCINOMA
Kose, F.; Abali, H.; Findikcioglu, A.; Canpolat, T.; Besen, A.A.; Sumbul, A.T.; Mertsoylu, H.; Sedef, A.M.; Ozyilkan, O. (2015) -
Prolonged Use of Bevacizumab May Cause Extensive Coronary Artery Thrombosis
Muallaoglu, S.; Disel, U.; Tekin, A.; Mertsoylu, H.; Abali, H.; Ozyilkan, O. (2014)